Jason Chesney, DO
Otolaryngology/Facial Plastic Surgery · East Lansing, MINPI 1407169535
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,296 of the $4,927 with a category attached, or 66.9%. 20 manufacturers reported payments, led by Intersect ENT, Inc. at 57.5% of the total. Reporting peaked in 2019 at $2,969 and has fallen 92.8% since, to $214 in 2025.
Across 60 payments — averaging $82.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$3K
- Medtronic$1K
- Acclarent, Inc$291
- GSK$141
- Sanofi$98
- Neurent Medical Limited$87
- plus $364 from 14 others
What the payments were for
- Travel & lodging$3,29667%
- Food & beverage$1,63133%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 8 | $2,834 |
| Medtronic | 11 | $1,112 |
| Acclarent, Inc | 10 | $291 |
| GSK | 9 | $141 |
| Sanofi | 4 | $98 |
| Neurent Medical Limited | 3 | $87 |
| Kerecis Limited | 1 | $45 |
| Aerin Medical Inc. | 2 | $43 |
| Novartis | 1 | $42 |
| Integra Lifesciences Corporation | 1 | $36 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| Stryker | 1 | $28 |
| Acera Surgical, Inc. | 1 | $25 |
| Pfizer | 1 | $20 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Xoran Technologies LLC | 1 | $16 |
| Alk-abello, Inc | 1 | $15 |
| KARL Storz Endoscopy-america | 1 | $14 |
| Optinose US, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$2,667
- SINUVA$2,667
- StealthStation$880
How this compares
$4,927 in reported general payments places this provider in the 80th percentile of 31 otolaryngology/facial plastic surgery providers in Michigan.
See all otolaryngology/facial plastic surgery providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 71 | $2,131 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 13 | $1,727 |
| Fluticasone Propionate | 61 | $892 |
| Fluocinolone Acetonide Oil | 11 | $388 |
| Ofloxacin | 14 | $154 |
| Mupirocin | 24 | $149 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in East Lansing
- Ahmed SufyanEast Lansing$16K
- Prasad ThottamWest Bloomfield$43K
- Warren BrandesMadison Heights$12K
- Amber BerryKalamazoo$9K
- Miles NeumannSouthfield$6K
- Kenneth GwinnShelby Township$5K
- Christine LepoudreNovi$5K
- Mark TomaDearborn$4K
- James SlaterPetoskey$4K
- Andrew ComptonWest Bloomfield$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.